HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm.

Br J Cancer · 2011 · PMC3048204 · PMID 21304524

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a definite trendno p-value reported

A definite trend could be seen from stage I to stage IV disease, and CA125 and HE4 performed significantly worse when early and late stages of disease were compared.

also in 240 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.